Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Spicer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|July 8, 1999
Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agentsS A Gamage, J A Spicer, G J Atwell, et al.
Anti-Cancer Drug Design|September 29, 1999
Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agentsJ A Spicer, S A Gamage, G J Atwell, et al.
Journal of Nuclear Medicine Technology|May 14, 1999
Unexpected stomach uptake of technetium-99m-MDPJ A Spicer, C K Slaton, T G Raveill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1979
The biodistribution of Br-77-labeled estrone: visualization of tissues containing increased estrogen receptorsJ A Spicer, D F Preston, R J Baranczuk, et al.
Journal of Medicinal Chemistry|April 20, 2001
Dicationic bis(9-methylphenazine-1-carboxamides): relationships between biological activity and linker chain structure for a series of potent topoisomerase targeted anticancer drugsS A Gamage, J A Spicer, G J Finlay, et al.
Journal of Medicinal Chemistry|February 7, 2001
Bis(phenazine-1-carboxamides): structure-activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugsJ A Spicer, S A Gamage, G W Rewcastle, et al.
European Journal of Drug Metabolism and Pharmacokinetics|August 27, 2014
The preclinical pharmacokinetic disposition of a series of perforin-inhibitors as potential immunosuppressive agentsM R Bull, J A Spicer, K M Huttunen, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1989
Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in boneR G Robinson, G M Blake, D F Preston, et al.
Cancer Research|December 15, 1990
Characterization of high specific activity [16 alpha-123I]Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumorsE J Pavlik, K Nelson, H H Gallion, et al.
Nature Communications|November 17, 2018
Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitisM Welz, S Eickhoff, Z Abdullah, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|July 8, 1999
Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agentsS A Gamage, J A Spicer, G J Atwell, et al.
Anti-Cancer Drug Design|September 29, 1999
Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agentsJ A Spicer, S A Gamage, G J Atwell, et al.
Journal of Nuclear Medicine Technology|May 14, 1999
Unexpected stomach uptake of technetium-99m-MDPJ A Spicer, C K Slaton, T G Raveill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1979
The biodistribution of Br-77-labeled estrone: visualization of tissues containing increased estrogen receptorsJ A Spicer, D F Preston, R J Baranczuk, et al.
Journal of Medicinal Chemistry|April 20, 2001
Dicationic bis(9-methylphenazine-1-carboxamides): relationships between biological activity and linker chain structure for a series of potent topoisomerase targeted anticancer drugsS A Gamage, J A Spicer, G J Finlay, et al.
Journal of Medicinal Chemistry|February 7, 2001
Bis(phenazine-1-carboxamides): structure-activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugsJ A Spicer, S A Gamage, G W Rewcastle, et al.
European Journal of Drug Metabolism and Pharmacokinetics|August 27, 2014
The preclinical pharmacokinetic disposition of a series of perforin-inhibitors as potential immunosuppressive agentsM R Bull, J A Spicer, K M Huttunen, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1989
Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in boneR G Robinson, G M Blake, D F Preston, et al.
Cancer Research|December 15, 1990
Characterization of high specific activity [16 alpha-123I]Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumorsE J Pavlik, K Nelson, H H Gallion, et al.
Nature Communications|November 17, 2018
Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitisM Welz, S Eickhoff, Z Abdullah, et al.
Pageof 2